China approves trials of home-grown mRNA vaccines as cases surge - South China Morning Post

4/3/2022 12:00:00 AM3 years 1 month ago

The approvals add CanSino and CSPC to the race among Chinese companies to use mRNA to fight the coronavirus, offering viable alternatives to the vaccines already in production by Pfizer and Moderna.

Published: 12:06pm, 4 Apr, 2022 Updated: 6:19pm, 4 Apr, 2022

full article...